全文获取类型
收费全文 | 25903篇 |
免费 | 2237篇 |
国内免费 | 1069篇 |
专业分类
耳鼻咽喉 | 279篇 |
儿科学 | 991篇 |
妇产科学 | 449篇 |
基础医学 | 1522篇 |
口腔科学 | 207篇 |
临床医学 | 3011篇 |
内科学 | 5763篇 |
皮肤病学 | 269篇 |
神经病学 | 1579篇 |
特种医学 | 609篇 |
外国民族医学 | 2篇 |
外科学 | 5664篇 |
综合类 | 3243篇 |
预防医学 | 1508篇 |
眼科学 | 336篇 |
药学 | 2237篇 |
14篇 | |
中国医学 | 981篇 |
肿瘤学 | 545篇 |
出版年
2024年 | 56篇 |
2023年 | 548篇 |
2022年 | 867篇 |
2021年 | 1496篇 |
2020年 | 1271篇 |
2019年 | 1128篇 |
2018年 | 1109篇 |
2017年 | 1084篇 |
2016年 | 1073篇 |
2015年 | 1045篇 |
2014年 | 1938篇 |
2013年 | 1949篇 |
2012年 | 1406篇 |
2011年 | 1599篇 |
2010年 | 1290篇 |
2009年 | 1350篇 |
2008年 | 1327篇 |
2007年 | 1200篇 |
2006年 | 1209篇 |
2005年 | 1004篇 |
2004年 | 765篇 |
2003年 | 651篇 |
2002年 | 518篇 |
2001年 | 457篇 |
2000年 | 352篇 |
1999年 | 299篇 |
1998年 | 209篇 |
1997年 | 219篇 |
1996年 | 197篇 |
1995年 | 141篇 |
1994年 | 184篇 |
1993年 | 113篇 |
1992年 | 123篇 |
1991年 | 89篇 |
1990年 | 97篇 |
1989年 | 84篇 |
1988年 | 73篇 |
1987年 | 56篇 |
1986年 | 77篇 |
1985年 | 67篇 |
1984年 | 74篇 |
1983年 | 51篇 |
1982年 | 65篇 |
1981年 | 59篇 |
1980年 | 53篇 |
1979年 | 46篇 |
1978年 | 34篇 |
1977年 | 25篇 |
1976年 | 27篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
目的探讨还原型谷胱甘肽(GSH)在预防糖尿病大鼠勃起功能障碍中的作用。方法通过腹腔注射链脲佐菌素65mg/kg建立糖尿病大鼠模型,然后随机分成DM组和DM+GSH组,DM+GSH组每天肌肉注射GSH200mg/kg。10周后观察大鼠勃起功能,并获取海绵体组织检测其谷胱甘肽、一氧化氮合酶(NOS)与丙二醛(MDA)水平,用TUNEL法检测细胞凋亡。结果成功建立糖尿病大鼠模型。与未注射GSH的DM组相比,DM+GSH组和正常对照组(C组)勃起功能更好,勃起率分别是20%,62.5%和100%。GSH水平DM+GSH组和C组明显比DM组高,其3组含量每克蛋白分别是(75.83±15.62)、(61.47±8.65)和(35.03±12.29)mg(P<0.05);NOS水平在DM+GSH组每毫克蛋白为(133.9±31.9)U,与正常对照组每毫克蛋白为(142.2±31.2)U相当,但较DM组每毫克蛋白为(58.4±18.9)U高(P<0.05);MDA含量在DM组每毫克蛋白为(3.71±0.62)nmol,明显高于正常对照组和DM+GSH组(P<0.05),这两组每毫克蛋白为(2.08±0.34)nmol和(2.44±0.28)nmol;细胞凋亡率在DM组、DM+GSH组和C组的分别是(22.6±3.6)%、(10.8±1.7)%和(7.2±2.1)%(P<0.05)。结论还原型谷胱甘肽对糖尿病大鼠阴茎组织有较好的抗氧化作用,能减少细胞凋亡,对延缓糖尿病性ED的发生有一定的作用。 相似文献
72.
应用前列腺素E1注射治疗勃起功能障碍8年经验 总被引:1,自引:0,他引:1
目的观察前列腺素E1(PGE1)注射治疗勃起功能障碍(ED)的长期疗效、副作用及预后。方法使用PGE1行阴茎海绵体注射,阴茎硬度检查仪(Rigiscan)连续记录1h,并根据观察结果,调查PGE1注射剂量,确定每例患者合适的注射量,掌握注射方法后回家自行注射。共筛选出ED患者410例,随访患者阴茎勃起情况、药量调整和副作用。结果410例ED患者中,心理性139例,静脉性83例,动脉性36例,神经性78例,混合性74例。对治疗满意的患者有256例(62.44%),其中21例(5.1%)在使用PGE15次后停用,并能达到满意的性生活而治愈。293例(71.46%)患者自述注射时有胀痛感。171例(43.17%)因疼痛(105例)、操作不便(25例)、副作用顾虑(37例)和其他原因(4例)而于6个月后放弃治疗。204例(49.76%)患者使用时间已超过1年,24例(5.85%)患者使用时间已超过5年,7例(1.7%)使用已有8年。未发现阴茎异常勃起和阴茎海绵体纤维化。注射损伤阴茎表面血管致瘀斑者有20例。有27例患者失访。结论PGE1是治疗ED的一种安全有效的药物,可以长期使用。其最常见的副作用是阴茎疼痛。Rigiscan能帮助确定PGE1的注射剂量。 相似文献
73.
Internal Hernias: Clinical Findings,Management, and Outcomes in 49 Nonbariatric Cases 总被引:1,自引:0,他引:1
Saber Ghiassi Scott Q. Nguyen Celia M. Divino John C. Byrn Avraham Schlager 《Journal of gastrointestinal surgery》2007,11(3):291-295
Internal hernia, the protrusion of a viscus through a peritoneal or mesenteric aperture, is a rare cause of small bowel obstruction.
We report the clinical presentation, surgical management, and outcomes of one of the largest series of nonbariatric internal
hernias. Ten-year retrospective review of patients at our institution yielded 49 cases of internal hernias. Majority of patients
presented with symptoms of acute (75%) or intermittent (22%) small bowel obstruction. While 16% of CT scans were suspicious
for internal hernia, in no cases the preoperative diagnosis of internal hernia was made. The most frequent internal hernias
were transmesenteric (57.0%) and 34 hernias (69%) were caused by previous surgery. All internal hernias were reduced and the
defects were repaired. Compromised bowel was present in 22 cases and 11 patients underwent small bowel resection. The mean
postoperative hospitalization was 10.9 days. The overall mortality rate from our series is 2%, and the morbidity rate is 12%.
Transmesenteric hernias, as complications of previous surgeries, are the most prevalent internal hernias. Preoperative diagnosis
of internal hernia is extremely difficult because of the nonspecific clinical presentation. However, if discovered promptly,
internal hernias can be repaired with acceptable morbidity and mortality.
Poster presentation at Digestive Disease Week, May 22, 2006, Los Angeles, California, USA. 相似文献
74.
瓣膜病合并肝功能不全患者的体外循环管理 总被引:5,自引:0,他引:5
目的 回顾52例瓣膜病变合并肝功能不全的行瓣膜置换术的患者,总结体外循环(CPB)经验。方法 CPB采取中度低温,保持较高的灌注压力。预充液加入白蛋白。心肌保护用高钾含血停搏液灌注。结果 结果CPB时间50~135min,主动脉阻断23~98min,心脏自动复跳率94%,无全心辅助和左心辅助,围术期死亡6人。结论 术中加强心肌保护的同时重视肝保护,可减轻术后心功能衰竭和肝功能衰竭,降低并发症和死亡率。 相似文献
75.
术后早期肠内营养对食管癌患者肠黏膜屏障功能的影响 总被引:23,自引:4,他引:19
目的 探讨食管癌患者术后早期施行肠内营养支持对胃肠道黏膜屏障的保护作用. 方法术前3个月内体重下降超过患病前体重20%的食管癌患者56例,按所给营养方法不同分为肠内营养组(n=30)和肠外营养组(n=26),观察两组患者的临床结果,分别于术后第1、4和8天测定两组患者尿乳果糖与甘露醇的比值、血浆内毒素、肿瘤坏死因子(TNF)、胃泌素和谷氨酰胺水平. 结果肠内营养组患者术后体重减轻较少,感染性并发症发生较少(P<0.01,0.05).术后第4天和8天,肠内营养组尿乳果糖与甘露醇比值、血浆内毒素和TNF较肠外营养组低(P<0.01),胃泌素、谷氨酰胺较肠外营养组高(P<0.01). 结论食管癌患者术后早期肠内营养对肠道黏膜屏障功能具有一定的保护作用,有可能减少术后感染性并发症的发生. 相似文献
76.
梗阻性左半结肠癌I期切除吻合术的探讨 总被引:3,自引:1,他引:2
目的探讨急性梗阻性左半结肠癌I期切除、吻合的可行性。方法采用术中肠管切开减压,近远端肠管顺行灌洗,I期肿瘤切除、吻合。结果15例患者除1例吻合口瘘经引流冲洗后治愈,余病例全部I期愈合。结论左半结肠癌引起肠梗阻,严格掌握手术适应证,合理围手术期处理,术中肠管减压、灌洗及术后扩肛,I期切除吻合术是安全可取的。 相似文献
77.
Kenji Shimada Fumi Matsumoto Mari Kawagoe Futoshi Matsui 《International journal of urology》2007,14(5):388-392
OBJECTIVE: It is well described that unilateral pelviureteric junction obstruction (PUJO) is a benign condition, because the dilatation resolves spontaneously and the function does not decrease in most of the kidneys. However, there is exceptional PUJO that requires emergent treatment in neonatal periods. The aim of this article is to report the urological emergency and management in neonates with PUJO. MATERIALS AND METHODS: Nine children (seven boys and two girls) with PUJO who underwent neonatal emergent treatment during the last 13 years were reviewed. Renal function was evaluated according to decay curve of serum creatinine (SCr) levels corresponding to gestational age (GA) at delivery. Physical examination, ultrasonographic monitoring, and chest and abdominal plain radiographs were repeated in each neonate. RESULTS: Eight patients were detected prenatally. In five patients, multicystic dysplastic kidney (MCDK) was demonstrated on the contralateral side. Three patients underwent percutaneous puncture of fetal hydronephrosis. Decrease of amniotic fluid was evident in three fetuses. Indications for emergent treatment included mass effect from hydronephrosis in three patients, renal dysfunction in five, and severe urinary tract infection in one. During neonatal periods, a percutaneous nephrostomy tube was placed in seven, and open nephrostomy in one with anorectal malformation. Repeated punctures of the dilated renal pelvis were done in one patient. Renal function after pyeloplasty was stable in eight patients, while it was moderately decreased in one who was associated with oligohydramnios in utero. CONCLUSION: Indications for emergent treatment in neonates with PUJO included mass effect from giant hydronephrosis, renal dysfunction and severe urinary tract infection. At birth, respiratory and circulatory conditions must first be stabilized. In neonates with hydronephrosis of the solitary kidney or severe bilateral PUJO, serial SCr should be monitored to evaluate renal function. Decrease of amniotic fluid suggested renal functional compromise that would not recover after urological management. 相似文献
78.
P. Subashini Dr. A. Ravikumar M.S. DNB DLORCS M. S. Ranjit V. K. Sairam R. P. Vatsanath S. Jayasree 《Indian journal of otolaryngology and head and neck surgery》2007,59(1):73-75
A two and half year old male child was seen with systemic hypertension, left ventricular dysfunction, mitral regurgitation and congestive cardiac failure. Examination revealed adenoid hypertrophy. He was also suffering from obstructive sleep apnea. He was being treated with anti-hypertensive and anti-failure drugs. Adenoidectomy was performed following which obstructive sleep apnea symptoms disappeared and his cardiac status improved markedly. Subsequently he was weaned off anti-hypertensive and anti-failure therapy. 相似文献
79.
80.
肠梗阻是临床常见的急腹症,绞窄性肠梗阻的死亡率可高达45%~30%,我们自1995年8月至1997年4月共收治肠梗阻53例,其中单纯性肠梗阻28例,经手术证实为绞窄性肠梗阻25例(其中肠坏死8例),在治疗前均测定血清磷、肌酸激酶及其同工酶,其结果:本组病例中血清磷升高者14例,其中以8例肠坏死为显著,肌酸激酶及其同功酶的升高也以绞窄性肠梗阻为明显,其中又以发病时间在48小时以内者和8例肠坏死者为著,因此,我们认为:血清磷、肌酸激酶及其同工酶的测定可以作为判断肠管是否发生绞窄及坏死的辅助诊断指标 相似文献